NDC 69238-1250

Bexarotene

Bexarotene

Bexarotene is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Bexarotene.

Product ID69238-1250_07cc3d0c-e7ca-4e17-be2e-bcceb187746f
NDC69238-1250
Product TypeHuman Prescription Drug
Proprietary NameBexarotene
Generic NameBexarotene
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2018-09-04
Marketing CategoryANDA / ANDA
Application NumberANDA210105
Labeler NameAmneal Pharmaceuticals NY LLC
Substance NameBEXAROTENE
Active Ingredient Strength75 mg/1
Pharm ClassesRetinoid [EPC], Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 69238-1250-1

1 BOTTLE in 1 CARTON (69238-1250-1) > 100 CAPSULE in 1 BOTTLE
Marketing Start Date2018-09-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69238-1250-1 [69238125001]

Bexarotene CAPSULE
Marketing CategoryANDA
Application NumberANDA210105
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-09-04

Drug Details

Active Ingredients

IngredientStrength
BEXAROTENE75 mg/1

OpenFDA Data

SPL SET ID:d7fc7c7b-2ecf-4543-8bb4-9b4415d66613
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 308725
  • UPC Code
  • 0369238125016
  • Pharmacological Class

    • Retinoid [EPC]
    • Retinoids [CS]

    NDC Crossover Matching brand name "Bexarotene" or generic name "Bexarotene"

    NDCBrand NameGeneric Name
    0054-0399Bexarotenebexarotene
    0378-6955BexaroteneBexarotene
    0591-2832bexarotenebexarotene
    0832-0285BexaroteneBexarotene
    42292-007BexaroteneBexarotene
    43975-315BexaroteneBexarotene
    68682-002bexarotenebexarotene
    68682-003bexarotenebexarotene
    69238-1250BexaroteneBexarotene
    69238-2088BexaroteneBexarotene
    0187-5525Targretinbexarotene
    0187-5526Targretinbexarotene

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.